Galveston, TXNCT07360314Now EnrollingIRB Ready

Advanced Solid Tumors Clinical Trial in Galveston, TX

Access cutting-edge advanced solid tumors treatment through this clinical trial at a research site in Galveston. Study-provided care at no cost to qualified participants.

Sponsored by EMD Serono Research & Development Institute, Inc.

Quick Self-Assessment

See if you qualify for this Galveston location

Preparing your pre-screening questions…

Expert Care in Galveston

Access advanced solid tumors specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related advanced solid tumors treatment provided free

Apply for This Galveston Location

Check if you qualify for this advanced solid tumors clinical trial in Galveston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Galveston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Galveston site if eligible
  4. 4Begin participation

About This Advanced Solid Tumors Study in Galveston

The purpose of this first-in-human (FIH) study is to evaluate the safety, tolerability, Pharmacokinetics (PK), and preliminary clinical activity of M7437 in participants with locally advanced or metastatic solid tumors with known Ly6E expression, including non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), epithelial ovarian carcinoma (EOC), squamous cell carcinoma of the head and neck (SCCHN), pancreatic ductal adenocarcinoma (PDAC), and gastric cancer (GC).

Sponsor: EMD Serono Research & Development Institute, Inc.

Who Can Participate

Inclusion Criteria

Participants have histologically proven advanced solid tumors with known prevalent and high Ly6E expression, Disease characteristic: Participants should have an unresectable locally advanced or metastatic solid tumor that is refractory to standard therapies, or have no standard therapies, or for which no standard therapy is judged appropriate by the Investigator. For each tumor type, participants have received prior lines of therapy, where locally available:
Non-small cell lung cancer (nonsquamous or squamous)
Triple-negative breast cancer
Squamous cell carcinoma of head and neck
Pancreatic ductal adenocarcinoma
Gastric cancer
Epithelial ovarian cancer
Participants with ECOG Performance Status (ECOG) less than and equal to (\<=) 1
Participants must have blood, liver, and kidney function within safe levels.
Other protocol defined inclusion criteria may apply

Exclusion Criteria

Participant has a history of another malignancy within 3 years before the date of enrollment (exceptions are squamous and basal cell carcinomas of the skin and carcinoma in situ of the cervix, benign prostate neoplasm/hyperplasia, or malignancy that in the opinion of the Investigator, with concurrence with the Sponsor's Medical Monitor, is considered cured with minimal risk of recurrence within 3 years before the date of enrollment). History of hematopoietic allogenic transplantation.
Participants with known brain metastases, except those meeting both of the following criteria:
All brain metastases have been treated locally and are clinically stable for at least 4 weeks prior to the start of treatment.
No ongoing neurological symptoms that are related to the brain localization of the disease (sequelae that are a consequence of the treatment of the brain metastases are acceptable).
Participants with diarrhea (liquid stool) or ileus Grade more than (\>) 1 within 1 week of Cycle1Day1.
Participants with active chronic inflammatory bowel disease and/or bowel obstruction.
Participants with history of serious gastrointestinal bleeding within 3 months of Cycle1Day1.
Other protocol defined exclusion criteria may apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Galveston?

Yes, this clinical trial (NCT07360314) has an active research site in Galveston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Advanced Solid Tumors Treatment Options in Galveston, TX

If you're searching for advanced solid tumors treatment options in Galveston, TX, this clinical trial (NCT07360314) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Galveston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all advanced solid tumors clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Galveston, TX

See all advanced solid tumors clinical trials recruiting in Galveston — not just this study.

Browse Advanced Solid Tumors Trials in Galveston

Ready to Join in Galveston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Galveston, TX